John Bamford

John Bamford

Auto-generated profile, based on publicly available information

John Bamford

Leeds General Infirmary

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in European Stroke Journal
Verified
Journal Article
Open access
PDF file
JAJoao Brainer Clares de Andrade
Joao Brainer Clares de Andrade
JMJay P Mohr
Jay P Mohr
FTFelipe Brito Timbó
Felipe Brito Timbó
CNCamila Rodrigues Nepomuceno
Camila Rodrigues Nepomuceno
JMJoão Vitor da Silva Moreira
João Vitor da Silva Moreira
JBJohn Bamford
John Bamford
Introduction: The Oxfordshire Community Stroke Project (OCSP) proposed a clinical classification for Stroke patients. This classification has proved helpful to predict the risk of neurological complications. However, the OCSP was initially based on findings on the neurological assesment, which can pose difficulties for classifying patients. We aimed to describe the development and the validation step of a computer-based algorithm based on the OCSP classification. Materials and methods: A flow-chart was created which was reviewed by five board-certified vascular neurologists from which a computer-based algorithm (COMPACT) was developed. Neurology residents from 12 centers were invited to participate in a randomized trial to assess the effect of using COMPACT. They answered a 20-item questionnaire for classifying the vignettes according to the OCSP classification. Each correct answer has been attributed to 1-point for calculating the final score. Results: Six-two participants agreed to participate and answered the questionnaire. Thirty-two were randomly allocated to use our algorithm, and thirty were allocated to adopt a list of symptoms alone. The group who adopted our algorithm had a median score of correct answers of 16.5[14.5, 17]/20 versus 15[13, 16]/20 points, p = 0.014. The use of our algorithm was associated with the overall rate of correct scores (p = 0.03). Discussion: Our algorithm seemed a useful tool for any postgraduate year Neurology resident. A computer-based algorithm may save time and improve the accuracy to classify these patients. Conclusion: An easy-to-use computer-based algorithm improved the accuracy of the OCSP classification, with the possible benefit of further improvement of the prediction of neurological complications and prognostication.

1 January 1990 in British Journal of Audiology
Verified
Journal Article
Closed access
JSJacqueline Stokes
Jacqueline Stokes
JBJohn M. Bamford
John M. Bamford
This paper examines the development of the ability to signal intentionality in hearing-impaired infants. Four infants were monitored from the time aids were accepted and worn consistently until an expressive vocabulary of ten words was recorded. The focus of the study was the child's developing ability to coordinate attention to both a person and an object. Longitudinal video-taping allowed analysis of the stages and rate at which these infants achieved this pattern of attention. These infants were found to follow a sequence of steps similar to that reported in studies of hearing children. This finding and its possible implications for early identification of hearing impairment are discussed.

15 April 2022 in BMJ Case Reports
Verified
Journal Article
Open access
PDF file
MTMatthew J Tanti
Matthew J Tanti
MMMelissa J Maguire
Melissa J Maguire
DWDaniel J Warren
Daniel J Warren
JBJohn Bamford
John Bamford
Alpha-methylacyl-CoA racemase (AMACR) deficiency is a rare peroxisomal disorder causing pristanic acid accumulation. Only 16 cases have been described so far. A female in her seventh decade presented with episodes of dysphasia, headache and sensory disturbance inconsistent with migraine, epilepsy or transient ischaemic attack. An MRI demonstrated unusual changes in the pons, red nuclei, thalami and white matter. Mitochondrial disease was suspected but detailed testing was negative. After eight years of symptoms, she developed a febrile encephalopathy with hemispheric dysfunction, focal convulsive seizures and coma. Her condition stabilised after one month. Lacosamide was continued for seizure prevention. The diagnosis remained elusive until whole genome sequencing revealed AMACR deficiency. Pristanic acid levels were highly elevated and dietary modification was recommended. Genetic peroxisomal disorders can present in older age; our patient is the oldest in the AMACR deficiency literature. Novel features in our case include central apnoea, dystonia and rapid eye movement behaviour disorder.

11 April 2002
Verified
Book Chapter
Closed access
GDGeoffrey Donnan
Geoffrey Donnan
BNB Norrving
B Norrving
JBJ M Bamford
J M Bamford
JBJulien Bogousslavsky
Julien Bogousslavsky
Controversy has surrounded the categorization of infarcts in the subcortex for many years and, in particular, the relevance of the concept of lacunar infarction. If anything, the introduction of sophisticated imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI) has intensified the debate because the original classification was essentially a clinical one based on limited clinico- pathological correlations; latterly, the more recent and frequent clinico-radiological correlations have exposed the frailty of this classification. Specifically, it has been shown that a number of different pathologies may express identical clinical syndromes, the best example of which is the myriad of reported pathologies causing pure motor hemiplegia. The burgeoning number of publications in this area suggests that there is a real need to develop a structure for their classification and terminology. This may enable patients with common clinical, radiological, and perhaps pathological features to be grouped more precisely to allow the study of pathogenesis, prognosis, and, hopefully, treatment. The genesis of the proposed classification came from a meeting on ‘Lacunar and Other Subcortical Infarctions’ held in Lausanne, Switzerland in 1992. The major participants are shown in Fig. 3.1.

1 August 2005 in Journal of Interprofessional Care
Verified
Journal Article
Closed access
AYAlys Young
Alys Young
WMWendy McCracken
Wendy McCracken
HTHelen Tattersall
Helen Tattersall
JBJohn Bamford
John Bamford
This article presents data from a study undertaken as part of the national evaluation of the introduction of the newborn hearing screening programme (NHSP) in England. It considers the impact on Education and Social Services of NHSP from the perspective of how each agency perceives each other's role in circumstances where NHSP is requiring a greater focus on interagency and interprofessional working. The qualitative interview study involved 27 education and 15 social services respondents from phase 1 NHSP sites. It reveals considerable agreement on the poorly developed nature of joint working but considerable disagreement about the roots of such. Education is more likely to focus on issues of role, value and skills; social services on conflicts of ethos and culture. The problem of social services' capacity to respond to referrals concerning deaf children was common to both. The findings are placed in the context of government guidance, in particular Early Support and Children's Trusts, both of which support a strategic and statutory basis for interprofessional working in this context.

6 August 2025 in medRxiv
Verified
Preprint
Open access
PDF file
PBPhilip M. Bath
Philip M. Bath
LILACI-2 Trial Investigators
LACI-2 Trial Investigators
LWLisa J Woodhouse
Lisa J Woodhouse
IMIris Mhlanga
Iris Mhlanga
JBJohn M Bamford
John M Bamford
JWJoanna M Wardlaw
Joanna M Wardlaw
Background: Lacunar stroke, a type of cerebral small vessel disease (cSVD), causes cognitive decline and dependency. The LACunar Intervention Trial-2 (LACI-2) trial showed that 12 months of treatment with isosorbide-mononitrate (ISMN) and/or cilostazol improved these outcomes. We tested whether this effect was present at 6 months, a pre-specified analysis. Methods: LACI-2 assessed the feasibility, safety and proof-of-concept of one year of ISMN (40-60mg) and/or cilostazol (200 mg) using a prospective randomised open-label blinded-endpoint 2×2-factorial phase-2b design. Participants aged>30yrs had clinical lacunar stroke, compatible brain imaging and capacity to consent. Key outcomes included cognition (Diagnostic and Statistical Manual version 5-7-level, DSM5-7L), dependency, vascular events, mood, stroke impact and a global analysis of these. Results: Baseline characteristics were balanced across 363 participants: median age 64 [56-72] years, females 31% and median onset-to-randomisation 79 [27-244] days. At 6 months, participants allocated to ISMN vs control had fewer vascular-cognition-dependency events (adjusted odds ratio, aOR 0.74, 95% confidence intervals 0.55-0.99) and an improved stroke impact scale score (Mann-Whitney difference, MWD - 0.15, 95% CI −0.25, −0.05) and global analysis (MWD −0.06, 95% CI −0.11, −0.01). Cilostazol vs control reduced cognitive impairment (DSM5-7-level scale, acOR 0.64, 95% CI 0.41-0.99). Combined ISMN/cilostazol vs control (n=181) had improved cognition (DSM5-7L acOR 0.40, 95% CI 0.21-0.78) and mood (Zung aMD −6.94, 95% CI −12.25, −1.64), reduced stroke impact (−0.23, 95% CI −0.37, −0.09) and a better global outcome (MWD −0.10, 95% CI −0.17, −0.03). Conclusions: Improvements in cognitive and functional outcomes were seen within 6 months of ISMN and/or cilostazol. Registration: ISRCTN14911850 : https://www.isrctn.com/ISRCTN14911850